Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Borg

Showing results (131-140 of 224) with videos related to

Pageof 23
Sort By:
Mabs|March 30, 2017
A new anti-mesothelin antibody targets selectively the membrane-associated formKamal Asgarov, Jeremy Balland, Charline Tirole, et al.
Experimental Hematology & Oncology|March 4, 2016
New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignanciesClémentine Gamonet, Elodie Bole-Richard, Aurélia Delherme, et al.
Cancer Medicine|August 21, 2018
Randomized, double-blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancerDavid Fogelman, Antonio Cubillo, Pilar García-Alfonso, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 29, 2016
IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent MannerRomain Loyon, Emilie Picard, Olivier Mauvais, et al.
European Journal of Cancer (Oxford, England : 1990)|October 5, 2023
Time to recurrence and its relation to survival after recurrence in patients resected for stage III colon cancerCosimo Rasola, Pierre Laurent-Puig, Thierry André, et al.
Oncoimmunology|July 29, 2016
Immunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4(+) Th1 responses against telomerase in cancer patientsCaroline Laheurte, Jeanne Galaine, Laurent Beziaud, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2017
Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent mannerTakouhie Mgrditchian, Tsolere Arakelian, Jérôme Paggetti, et al.
Experimental Hematology & Oncology|April 16, 2016
Erratum to: New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignanciesClémentine Gamonet, Elodie Bole-Richard, Aurélia Delherme, et al.
International Journal of Cancer|March 31, 2020
Molecular description of ANGPT2 associated colorectal carcinomaMarine Jary, Reyhan Hasanova, Angélique Vienot, et al.
Oncoimmunology|June 7, 2018
PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancerMagalie Dosset, Thaiz Rivera Vargas, Anaïs Lagrange, et al.
Pageof 23

Showing results (131-140 of 224) with videos related to

Sort By:
Pageof 23
Mabs|March 30, 2017
A new anti-mesothelin antibody targets selectively the membrane-associated formKamal Asgarov, Jeremy Balland, Charline Tirole, et al.
Experimental Hematology & Oncology|March 4, 2016
New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignanciesClémentine Gamonet, Elodie Bole-Richard, Aurélia Delherme, et al.
Cancer Medicine|August 21, 2018
Randomized, double-blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancerDavid Fogelman, Antonio Cubillo, Pilar García-Alfonso, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 29, 2016
IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent MannerRomain Loyon, Emilie Picard, Olivier Mauvais, et al.
European Journal of Cancer (Oxford, England : 1990)|October 5, 2023
Time to recurrence and its relation to survival after recurrence in patients resected for stage III colon cancerCosimo Rasola, Pierre Laurent-Puig, Thierry André, et al.
Oncoimmunology|July 29, 2016
Immunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4(+) Th1 responses against telomerase in cancer patientsCaroline Laheurte, Jeanne Galaine, Laurent Beziaud, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2017
Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent mannerTakouhie Mgrditchian, Tsolere Arakelian, Jérôme Paggetti, et al.
Experimental Hematology & Oncology|April 16, 2016
Erratum to: New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignanciesClémentine Gamonet, Elodie Bole-Richard, Aurélia Delherme, et al.
International Journal of Cancer|March 31, 2020
Molecular description of ANGPT2 associated colorectal carcinomaMarine Jary, Reyhan Hasanova, Angélique Vienot, et al.
Oncoimmunology|June 7, 2018
PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancerMagalie Dosset, Thaiz Rivera Vargas, Anaïs Lagrange, et al.
Pageof 23